According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2021 the company made a revenue of $0.13 B an increase over the years 2020 revenue that were of $0.07 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $0.13 B | 6.92% |
2021 | $0.13 B | 65.43% |
2020 | $0.07 B | -13.2% |
2019 | $0.09 B | 15.6% |
2018 | $0.07 B | -15.88% |
2017 | $0.09 B | 3.04% |
2016 | $0.09 B | -2.23% |
2015 | $0.09 B | 53.12% |
2014 | $0.06 B | 115.02% |
2013 | $0.02 B | 8.46% |
2012 | $0.02 B | -23.27% |
2011 | $0.03 B | 1922.88% |
2010 | $1.67 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $42.82 B | 30,585.22% | ๐บ๐ธ USA |
![]() General Electric GE | $74.48 B | 53,275.23% | ๐บ๐ธ USA |
![]() Illumina ILMN | $4.65 B | 3,236.53% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $5.02 B | 3,497.39% | ๐บ๐ธ USA |
![]() Luminex LMNX | N/A | -100.00% | ๐บ๐ธ USA |
![]() NanoString Technologies NSTG | $0.14 B | 3.58% | ๐บ๐ธ USA |